Pimavanserin (Nuplazid®): Potential adverse effects

Worsening of Parkinsonism? Obviously, careful evaluation was done to see if pimavanserin worsened motor symptoms when used in patients with Parkinson’s disease. No worsening was found (Mathis et al., 2017). Common adverse effects Adverse effects occurring at least twice as often as on placebo include: Peripheral edema (7% vs 2%) Gait disturbance (2% vs <1%)…